A cooperative role of NRF2 and C/EBPβ (a transcription factor of the CCAAT/enhancer binding protein family) was described in generating tumor-specific enhancers that promote tumor initiation via NOTCH3 activation (Okazaki et al, 2020). The gene discussed is CEBPB; the disease is neoplasm.